Oct. 12 Presentation Focuses on Fair, Impartial Policing
Fair and Impartial Policing: A Science-Based Approach
When:
7-9 p.m., Monday, Oct. 12
Where:
Tangeman University Center's Mainstreet Cinema (second floor, food court level)
RSVP Required:
513-558-5607 or joseph.waddle@uc.edu
Police agencies and community stakeholders recognize that even the best officers might manifest bias and, therefore, must be proactive to achieve fair and impartial policing.
The two-hour session will include a presentation on the (1) science of bias and (2) the implications of the science for police policy and practice. Attendees will learn about explicit and implicit bias, understand how each of these might manifest in policing, and learn what agencies must do to combat biased policing. Attendees also will learn about training the University of Cincinnati Police Department is providing its officers based on this science. Comments and questions are welcome.
Presenter:
Lorie Fridell is a professor at the University of South Florida and former director of research at the Police Executive Research Forum (PERF). She is a Co-PI on the National Institute of Justice-funded National Police Research Platform and has over 20 years of experience conducting research on police use of force and violence against police.
Related Stories
Join the Information Security Outreach Roadshow
December 11, 2023
The UC Office of Information Security announces the Information Security Outreach Roadshows, interactive sessions designed to enhance cybersecurity skills university-wide. Starting January 2024, the program covers key topics like password management and phishing awareness, fostering a stronger digital security community at UC.
UC grads celebrate while looking to future
December 8, 2023
UC celebrated fall commencement at Fifth Third Arena, recognizing more than 2,500 graduates.
Local 12: UC stroke study aims to give patients more treatment...
December 8, 2023
The University of Cincinnati's Pooja Khatri and Eva Mistry spoke with Local 12 about the SISTER trial that will test a new drug to treat patients with strokes who are not eligible to receive traditional treatments due to timing factors or risk of complications.